Table 2. General characteristics of the participants.
| Variables | Healthy (n=30) | Patients (n=39) | t/χ2 | P value |
|---|---|---|---|---|
| Age (years) | 55.40±12.96 | 54.08±13.26 | t=0.42 | 0.58 |
| Gender male, n (%) | 20 (66.66) | 24 (61.54) | χ2=0.93 | 0.66 |
| High (cm) | 166.20±6.99 | 168.82±7.65 | t=1.46 | 0.15 |
| Weight (kg) | 67.87±1.79 | 67.05±1.69 | t=0.33 | 0.74 |
| WBC (×103/μL) | 15.93±4.54 | |||
| CRP (μg/mL) | 120.58±59.52 | |||
| Lac (mM) | 2.63±1.60 | |||
| SOFA score | 7.26±3.23 | |||
| APACHE II score | 15.72±3.97 | |||
| STEAP4 mRNA | 1.14±0.15 | 3.21±0.51 | t=3.5 | <0.01 |
| Diagnostic category, n (%) | ||||
| Cardiovascular | 3 (7.69) | |||
| Respiratory | 16 (41.03) | |||
| Abdominal | 14 (35.90) | |||
| Intracranial | 2 (5.13) | |||
| Urinary | 2 (5.13) | |||
| Cutaneous | 1 (2.56) | |||
| Unknown | 1 (2.56) |
The data are shown as n (%) or mean ± SD. WBC, white blood cell count; CRP, C-reactive protein; Lac, lactic acid; SOFA, Sequential Organ Failure Assessment; APACHE II, Acute Physiology and Chronic Health Assessment II; STEAP4, six-transmembrane epithelial antigen of the prostate 4.